Treatment effects of rivaroxaban vs warfarin in patients receiving no AAD were consistent with results from the overall trial ( primary end point : adjusted HR @ ; @ % CI @-@ @ ; Pinteraction = @ ; safety end point : adjusted HR @ ; @ % CI @-@ @ ; Pinteraction = @ ) .